CovidVax show full list
COVID-19 VACCINE:

Adeno-based - Sputnik V

researcher:
Gamaleya Research Institute
http://www.istc.int/en/institute/8333
(Russia)
vaccine type: Non-replicating viral vector

distribution (started in December 2020):
Albania, Algeria, Argentina, Armenia, Azerbaijan, Bahrain, Belarus, Bolivia, Bosnia and Herzegovina, Congo, Djibouti, Egypt, Ghana, Guinea, Guyana, Honduras, Hungary, India, Iran, Iraq, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lebanon, Libya, Mexico, Moldova, Mongolia, Montenegro, Nicaragua, North Macedonia, Oman, Pakistan, Palestine, Paraguay, Philippines, Russia, San Marino, Serbia, Sri Lanka, Syria, Tunisia, Turkmenistan, United Arab Emirates, Uzbekistan, Venezuela, Zimbabwe
Distribution updates
Mar 04RDIF announced the approval of the Russian Sputnik V vaccine by the Ministry of Health of the Republic of Iraq (by sputnikvaccine.com)
Mar 01Sputnik V vaccine against coronavirus has been given approval in the Slovak Republic (by sputnikvaccine.com)
Feb 19Sputnik V has been approved under emergency use authorization procedure by the Republic of San Marino (by sputnikvaccine.com)
Jan 21RDIF announced the UAE's MOHAP has authorized the use of Russian Sputnik V vaccine under emergency use authorization (by sputnikvaccine.com)
Jan 21Hungary has become the first country in EU to authorize the Sputnik V vaccine under emergency use authorization (by sputnikvaccine.com)
Jan 18Turkmenistan has become the first country in Central Asia to register Sputnik V vaccine under emergency use authorization (by sputnikvaccine.com)
Jan 15RDIF announced the approval of the Russian Sputnik V vaccine by Paraguay's Ministry of Health (by sputnikvaccine.com)
Jan 13RDIF announced the registration of the Russian Sputnik V vaccine by Venezuela's Ministry of Health (by sputnikvaccine.com)
Jan 11Palestinian health authorities has approved russian's Sputnik V for use in Palestinian self-ruled territory (by reuters.com)
Jan 10Algeria has become the first country in Africa to register Sputnik V vaccine under emergency use authorization (by sputnikvaccine.com)
Jan 06RDIF and the Government of Serbia announced the agreement to supply 2 million doses of Sputnik V (by sputnikvaccine.com)
Jan 06RDIF announced the registration of the Russian Sputnik V vaccine by Bolivia's AGEMED under emergency use authorization (by sputnikvaccine.com)
Dec 23Argentina was the first country in Latin America to officially register Sputnik V under emergency use authorization (by sputnikvaccine.com)
Jul 16Russia plans to domestically produce 30m doses of Gamaleya's vaccine this year (by reuters.com)
Human Testing updates (clinical trials)

PHASE 1-2

 

started June 17 2020

with 38 healthy volunteers aged 18-60

trial location: Moscow, Russia

» clinical trial details

PHASE 1-2

 

started January 15 2021

with 110 healthy volunteers 18+

trial location: Saint Petersburg, Russia

» clinical trial details

PHASE 2

 

started October 22 2020

with 110 healthy volunteers aged 18-60

trial location: Moscow, Russia

» clinical trial details

PHASE 2-3

 

started December 2020

with 1600 healthy volunteers 18+

trial location: India

» clinical trial details

PHASE 3 (Belarus)

 

started September 28 2020

with 100 healthy volunteers aged 18-60

trial location: Minsk, Belarus

» clinical trial details

PHASE 3 (Russia)

 

started August 31 2020

with 40000 healthy volunteers 18+

trial location: Moscow, Russia

» clinical trial details

PHASE 3 (Venezuela)

 

started November 2020

with 2000 healthy volunteers 18+

trial location: Venezuela

» clinical trial details

PHASE 3 (UAE)

 

started December 2020

with 1000 healthy volunteers 18+

trial location: United Arab Emirates

» clinical trial details

PHASE 3 (Russia)

 

started February 15 2021

with 6000 healthy volunteers 18+

trial location: Russia

» clinical trial details

Dec 14Sputnik V vaccine's efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials (by sputnikvaccine.com)
Sep 20Over 60000 people have applied to volunteer for Sputnik V's trials in Moscow (by tass.com)
Sep 07Gamaleya Institute's Sputnik V is about to start its Phase 3 clinical trials with first volunteers (by tass.com)
Sep 04RDIF and Gamaleya Institute published a scientific article on the results of Phase 1/2 clinical trials (by thelancet.com)
Sep 01Gamaleya's vaccine will be distributed among Moscow outpatients clinics on Sep 3-4 (by tass.com)
Aug 26RDIF, Moscow's government and Gamaleya announced the start of a post-registration clinical trial (by rdif.ru)
Aug 11Russia became the first country to grant regulatory approval to vaccine developed by Gamaleya (by reuters.com)
Jul 16Gamaleya's first clinical trial reported positive results by inducing animmune response (by clinicaltrialsarena.com)
Jun 18Gamaleya's vaccine is being tested by Russia which started a national clinical trial of it (by trialsitenews.com)
Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
Mar 04The RDIF announced the start of a rolling review procedure of Sputnik V vaccine against coronavirus by EMA (by sputnikvaccine.com)
Feb 25The RDIF announced that Sputnik V vaccine is now registered in 37 countries with total population of over 1.1 billion people (by sputnikvaccine.com)
Dec 21Belarus has become the first foreign country to register the Sputnik V vaccine (by sputnikvaccine.com)



funding:
Russian Direct Investment Fund (RDIF)
partnerships:
Mar 09Russia has signed a deal with Adienne Srl to produce Sputnik V vaccine in Italy planning to make 10 million doses this year (by apnews.com)



contact | about | ©2020 CovidVax.org project